Does omalizumab impair glucose homeostasis in a patient with severe persistent asthma and type 2 diabetes mellitus?

Documenti analoghi

• Seasonal omalizumab reduces allergen-specific immunoglobulin E levels in patients with Japanese cedar pollinosis and asthma
  di: S. Hamada
  Pubblicazione: (2017)
• Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal
  di: A.S. Sousa
  Pubblicazione: (2015)
• Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
  di: M. Pereira Barbosa
  Pubblicazione: (2015)
• Reference values for maximum respiratory pressures in patients with type 2 diabetes mellitus
  di: P. Caitano Fontela
  Pubblicazione: (2016)
• Consensus for the use of flash glucose monitoring in the Colombian adult population with type 1 and 2 diabetes mellitus
  di: ANA MARÍA GÓMEZ-MEDINA
  Pubblicazione: (2022)